Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Tax Provisions: 2021-2025

Historic Tax Provisions for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $500,000.

  • Immunocore Holdings' Tax Provisions rose 118.92% to $500,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 117.37%. This contributed to the annual value of -$1.9 million for FY2024, which is 66.98% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Tax Provisions is $500,000, which was down 17.49% from $606,000 recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Tax Provisions peaked at $1.5 million during Q2 2024, and registered a low of -$5.9 million during Q4 2023.
  • In the last 3 years, Immunocore Holdings' Tax Provisions had a median value of $300,000 in 2023 and averaged -$471,091.
  • Within the past 5 years, the most significant YoY rise in Immunocore Holdings' Tax Provisions was 685.34% (2024), while the steepest drop was 1,410.29% (2024).
  • Over the past 4 years, Immunocore Holdings' Tax Provisions (Quarterly) stood at -$289,000 in 2021, then reached -$5.9 million in 2023, then soared by 82.24% to -$1.1 million in 2024, then spiked by 118.92% to $500,000 in 2025.
  • Its Tax Provisions stands at $500,000 for Q3 2025, versus $606,000 for Q2 2025 and $1.1 million for Q1 2025.